You are right maysgr the valuation is effective till 30/9 and only accounts for the cash statement till 30/6 in the balance sheet
which is all they have to use.
My contingency plan to this would be to hopefully drag this out so that the court appointed date wouldnt be before the half yearly accounts would be due and finalised (mid-late Feb I believe)and hence our grounds for unfair price is that we have another six months income on the balance sheet and therefore request the new IER be based on those figures as this directly affects the valuation!
That would definetely increase the price and the court would reject their offer.
Does this seem a feasable outcome?
Regards
smartchemist
- Forums
- ASX - By Stock
- RRP
- Ann: Compulsory Acquistion Notice and IER
Ann: Compulsory Acquistion Notice and IER, page-61
-
-
- There are more pages in this discussion • 127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RRP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online